Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2)

Showing 2 of 2 trials
NCT04079582Not ApplicableActive Not Recruiting

Outcomes of a Higher vs. Lower Hemodialysate Magnesium Concentration (Dial-Mag)

Role: collaborator

NCT02274298Not ApplicableUnknown

Improving Care for Patients With Chronic Kidney Disease Using EMRALD

Role: collaborator

All 2 trials loaded